Zhang Yujing
Chief physician
Radiation Oncology
Sun Yat-sen University Cancer Center
China
Biography
Prof. Zhang specializes in clinical work of oncology radiotherapy and combination therapy, and relevant radiation and molecular biological studies, especially radiotherapy and research of gastrointestinal tumors and soft tissue sarcoma such as lymphoma, breast cancer, gastric cancer and pancreatic cancer. Work experience 1995-1999: Served as a physician and attending physician in the Department of Radiotherapy, Cancer Center of Qilu Hospital of Shandong University; 2002-present: associate chief physician of Radiation Oncology at Sun Yat-sen University Cancer Center; 2008-2009: Conducted research work at Texas Children's Cancer Center of Baylor College of Medicine; 2010-2011: Guest doctor and supporting expert for the Department of Breast and Thoracoabdomine at Cancer Hospital of Xinjiang Medical University.
Research Interest
Prof. Zhang specializes in clinical work of oncology radiotherapy, especially radiotherapy and combination therapy for lymphoma, breast cancer, gastropancreatic tumor, and soft tissue sarcoma. He has been engaging himself in the clinical and relevant researches of the above-mentioned cancer in renowned cancer centers at home and abroad, accumulating abundant experiences from his 20 years of clinical practices. He conducts in-depth researches of radiotherapy of breast cancer and radiotherapy indications of early breast cancer; masters and has unique insights into diagnosis and treatment of extranodal NK/T-cell lymphoma, nasal type, and primary extranodal lymphoma in locations such as Waldeyer's tonsillar ring, gastrointestine, bone, breast and orbit; takes the lead in adopting new IMRT for radiotherapy and combination therapy for gastric cancer and pancreatic cancer. He had undertaken doctoral and postdoctoral researches in the field of oncology molecular radiobiology in a renowned cancer laboratory, research interest including radiobiology of high LET ray, regulation and control of radiosensitivity of cancer stem cells, individualized prediction of radiation effects of cancer tissue and normal tissue and etc.